Document is current
Any future updates will be listed below
-
Authors
Rocca, Walter A. https://orcid.org/0000-0002-1832-7664
Gazzuola Rocca, Liliana
Smith, Carin Y. https://orcid.org/0000-0002-3610-6945
Esterov, Dmitry
Kapoor, Ekta
St. Sauver, Jennifer L.
Stewart, Elizabeth A.
Kantarci, Kejal
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Aging (U54 AG044179, RF1 AG055151, R33 AG058738)
Mayo Clinic Research Committee
- License Information
-
More Information
Article History
Received: 3 December 2024
Accepted: 10 June 2025
First Online: 10 July 2025
Competing interests
: E.K. has no conflicts of interest directly related to the subject of this manuscript. However, over the past 36 months she has had the following conflicts of interest: She has been a consultant for Astellas Pharmaceuticals, Estetra SRL, WellFound Inc., Fresenius Kabi USA Inc., and Exeltis. E.A.S. has no competing interest directly related to the subject of this paper. However, over the past 36 months she has the following conflicts of interest: She has been a consultant for AbbVie, Anylyn, and ASKA pharmaceuticals related to uterine fibroids or heavy menstrual bleeding. Her institution receives active research support regarding adenomyosis (R01 HD105714) and uterine fibroids (R01HD109127-01A1 and P50HD115283) from the Eunice Kennedy Shiver Institute of Child Health and Human Development, National Institutes of Health and research support from PCORI related to infertility (PLACER-2023C3-35477). She holds a patent for Methods and Compounds for Treatment of Abnormal Uterine Bleeding (US 6440445), which has no commercial activity. She has received royalties from UpToDate and payments for the development of educational content from Omia, Omnicuris, Med-IQ, PER, and Web MD. She serves as an unpaid advisor to The Fibroid Foundation and the unpaid treasurer of the International Gynecologic Society. The other authors declare that they have no competing interest.
